“No one should die of malignant melanoma” - A. Bernard Ackerman, 1985

Skin Cancer
Institute Blog

[6 min watch] Second opinion & clinico-pathologic correlation Part 3: Prof Giuseppe Argenziano

By Skin Cancer Institute |November 24, 2021 posted in skin cancer diagnosis, melanoma, pathology

In this final part of a three-part series, Prof Giuseppe Argenziano discusses the way in which a second opinion by an experienced dermatopathologist can significantly improve the clinical management ...
Read More

[5 min read] Melanoma size not a reliable predictor of invasion | Prof David Wilkinson

By Skin Cancer Institute |November 15, 2021 posted in skin cancer diagnosis, melanoma

This month’s paper is from the SCARD database, and reports on the features of over 600 melanomas diagnosed by almost 30 GPs across Australia.
Read More

[5 min watch] Second opinion & clinico-pathologic correlation Part 2: Prof Giuseppe Argenziano

By Skin Cancer Institute |October 19, 2021 posted in skin cancer diagnosis, melanoma, pathology

In this second part of a four-part series, Prof Giuseppe Argenziano discusses the way in which a second opinion by an experienced dermatopathologist can significantly improve the clinical management ...
Read More

[10 min read] Sentinel lymph node biopsy: Where do we stand?

By Skin Cancer Institute |September 06, 2021 posted in melanoma, biopsy

This month’s research article is about sentinel lymph node biopsy (SLNB), and is in the form of a viewpoint from two clinicians at the centre of excellence that is Memorial Sloan Kettering Cancer ...
Read More

Managing melanoma in the future: Prof Giuseppe Argenziano | August 2021

By Skin Cancer Institute |August 17, 2021 posted in melanoma, melanoma treatment

In this skin cancer update video, Professor Giuseppe Argenziano shares a few thoughts on the future of managing melanoma. In particular, he speaks about possible changes to excision, follow-up, ...
Read More

Recent Posts